Mechanism-Based Therapies for the Treatment of Portal Hypertension
Nov
16
2024
Convention Center: Ballroom 6A
8:00 AM - 9:30 AM
Captured
World Class Speakers
Description
Organized by the portal hypertension SIG, this session provides an update on new therapies based on the mechanisms of portal hypertension and chronic liver disease, with special emphasis on current knowledge regarding relevant pathophysiology, new preclinical and clinical data, and controversies in the field.Journey Maps
Presentations
8:00 AM - 8:20 AM
Nov
16
2024
San Diego, CA
Basic Mechanisms Underlying Portal Hypertension
Jordi Gracia-Sancho, PhD, FAASLD, Presenter
ALD
Cirrhosis and Portal Hypertension
8:20 AM - 8:45 AM
Nov
16
2024
San Diego, CA
Do We Currently Have Anything That Really Works for Portal Hypertension?
Tamar Taddei, MD, MD, FAASLD, Presenter
ALD
Cirrhosis and Portal Hypertension
8:45 AM - 8:55 AM
Nov
16
2024
San Diego, CA
Point-Counterpoint: Early Transjugular Intrahepatic Portosystemic Shunt (For/Pro)
Mattias Mandorfer, MD PhD, Presenter
ALD
Cirrhosis and Portal Hypertension
8:55 AM - 9:05 AM
Nov
16
2024
San Diego, CA
Point-Counterpoint: Early Transjugular Intrahepatic Portosystemic Shunt (Against/Con)
Lisa VanWagner, MD MSc, Presenter
ALD
Cirrhosis and Portal Hypertension
9:05 AM - 9:30 AM
Nov
16
2024
San Diego, CA
Exciting Developments on the Horizon for Portal Hypertension
Lise Lotte L Gluud, Presenter
ALD
Cirrhosis and Portal Hypertension
Objectives
- Describe the cellular and molecular mechanisms of portal hypertension in the context of chronic liver disease.
- Review the data regarding current and potential therapeutic options for portal hypertension including pharmacologic and interventional approaches.